International Diabetes Federation
Follow the titration schedule : Slow, gradual dose increases give your body time to adapt to each level of weight loss
Retatrutide is not yet FDA approved, but like many GLP-1 agonists such as Wegovy (semaglutide) and Mounjaro (tirzepatide), retatrutide will most likely be a weekly injection, delivered subcutaneously into the arm, thigh or stomach area in a self-inject pen
The peptide shelf life considerations and tirzepatide shelf life analysis explore degradation timelines that inform smart purchasing quantities
chemical degradation such as oxidation may not be visible and requires HPLC analysis to confirm
A qualified healthcare provider should evaluate your complete medical history, current medications, and genetic risk factors before selecting a specific GLP-1 medication and dosing strategy